(Total Views: 610)
Posted On: 03/22/2021 8:22:18 PM
Post# of 148899
“Fluorescently tagged Pro 140 has been used since Progenics was running tests.”
Not in CYDY trials. See the PR below:
https://www.cytodyn.com/investors/news-events...-occupancy
“today announced the completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab. Development of this test could more precisely guide CytoDyn in identification of patients at screening for monotherapy.”
Not in CYDY trials. See the PR below:
https://www.cytodyn.com/investors/news-events...-occupancy
“today announced the completion of development of the Receptor Occupancy Test to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab. Development of this test could more precisely guide CytoDyn in identification of patients at screening for monotherapy.”
(1)
(0)Scroll down for more posts ▼
